Loss of Yes-associated protein (YAP) expression is associated with estrogen and progesterone receptors negativity in invasive breast carcinomas

被引:73
作者
Tufail, Rozina [1 ]
Jorda, Mercy [2 ]
Zhao, Wei [3 ,4 ]
Reis, Isildinha [3 ,4 ]
Nawaz, Zafar [1 ]
机构
[1] Univ Miami, Braman Family Breast Canc Inst, Dept Biochem & Mol Biol, Sylvester Comprehens Canc Ctr,Miller Sch Med, Miami, FL 33136 USA
[2] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Braman Family Breast Canc Inst,Dept Pathol, Miami, FL 33136 USA
[3] Univ Miami, Sylvester Biostat Div, Braman Family Breast Canc Inst, Miller Sch Med,Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA
[4] Univ Miami, Dept Epidemiol & Publ Hlth, Braman Family Breast Canc Inst, Sylvester Comprehens Canc Ctr,Miller Sch Med, Miami, FL 33136 USA
关键词
Yes-associated protein; Estrogen receptor; Progesterone receptor; Breast cancer; E6-ASSOCIATED PROTEIN; STEROID-RECEPTORS; GROWTH-CONTROL; WW DOMAINS; IN-SITU; CANCER; COACTIVATOR; GLAND;
D O I
10.1007/s10549-011-1435-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Yes-associated protein (YAP) is a well characterized transcriptional coactivator that interacts with various transcription factors and modulates their transcriptional activities. Phosphorylation of YAP by specific kinases regulates its cellular distribution and transcriptional activation functions. Sequestration of phosphorylated YAP in cytoplasm results in the reduction of transcription from its target genes. Since, YAP has been characterized as a coactivator of estrogen (ER) and progesterone (PR) receptors, we examined the immunohistochemical expression profile of YAP and correlation of YAP expression with that of ER and PR in normal (40 samples) and tumor breast (226 samples) from microarray tissue samples using immunohistochemistry. Here we show that YAP expression is significantly reduced in invasive carcinoma samples compared to normal breast tissues, which express high levels of YAP (YAP was positive for 45.1% of invasive carcinoma samples versus 82.5% of normal samples P < 0.0001). Furthermore, the data shows that reduced expression of YAP in invasive carcinoma samples is significantly associated with ER negativity (YAP was negative for 59.9% in ER negative versus 38.9% in ER positive invasive carcinoma samples, P = 0.007) and PR negativity (YAP was negative for 60.1% in PR negative versus 28.9% in PR positive, P = 0.0004). Among invasive carcinoma samples, 42.9% were YAP, ER, and PR negative, whereas only 7.5% were found to be YAP, ER, and PR positive. On the contrary, 20 out of 23 (87%) normal breast tissues that were positive for ER and PR were also positive for YAP. These data suggest that YAP may act as a tumor suppressor in invasive breast carcinomas and it can also be used as a molecular marker for ER and PR negative breast tumors.
引用
收藏
页码:743 / 750
页数:8
相关论文
共 27 条
[1]   Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution [J].
Allred, D. Craig ;
Wu, Yun ;
Mao, Sufeng ;
Nagtegaal, Iris D. ;
Lee, Sangjun ;
Perou, Charles M. ;
Mohsin, Syed K. ;
O'Connell, Peter ;
Tsimelzon, Anna ;
Medina, Dan .
CLINICAL CANCER RESEARCH, 2008, 14 (02) :370-378
[2]   Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis [J].
Basu, S ;
Totty, NF ;
Irwin, MS ;
Sudol, M ;
Downward, J .
MOLECULAR CELL, 2003, 11 (01) :11-23
[3]   ESTROGEN-DEPENDENT, TAMOXIFEN-RESISTANT TUMORIGENIC GROWTH OF MCF-7 CELLS TRANSFECTED WITH HER2/NEU [J].
BENZ, CC ;
SCOTT, GK ;
SARUP, JC ;
JOHNSON, RM ;
TRIPATHY, D ;
CORONADO, E ;
SHEPARD, HM ;
OSBORNE, CK .
BREAST CANCER RESEARCH AND TREATMENT, 1992, 24 (02) :85-95
[4]   YAP At the crossroad between transformation and tumor suppression [J].
Bertini, Efrem ;
Oka, Tsutomu ;
Sudol, Marius ;
Strano, Sabrina ;
Blandino, Giovanni .
CELL CYCLE, 2009, 8 (01) :49-57
[5]   Ductal carcinoma in situ with basal-like phenotype:: a possible precursor to invasive basal-like breast cancer [J].
Bryan, BB ;
Schnitt, SJ ;
Collins, LC .
MODERN PATHOLOGY, 2006, 19 (05) :617-621
[6]  
CLARK GM, 1988, SEMIN ONCOL, V15, P20
[7]   Steroid receptors in human breast cancer [J].
Clarke, RB ;
Anderson, E ;
Howell, A .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2004, 15 (07) :316-323
[8]   WW domain binding protein-2, an E6-associated protein interacting protein, acts as a coactivator of estrogen and progesterone receptors [J].
Dhananjayan, Sarath C. ;
Ramamoorthy, Sivapriya ;
Khan, Obaid Y. ;
Ismail, Ayesha ;
Sun, Jun ;
Slingerland, Joyce ;
O'Malley, Bert W. ;
Nawaz, Zafar .
MOLECULAR ENDOCRINOLOGY, 2006, 20 (10) :2343-2354
[9]   YAP dysregulation by phosphorylation or ΔNp63-mediated gene repression promotes proliferation, survival and migration in head and neck cancer subsets [J].
Ehsanian, R. ;
Brown, M. ;
Lu, H. ;
Yang, X. P. ;
Pattatheyil, A. ;
Yan, B. ;
Duggal, P. ;
Chuang, R. ;
Doondeea, J. ;
Feller, S. ;
Sudol, M. ;
Chen, Z. ;
Van Waes, C. .
ONCOGENE, 2010, 29 (46) :6160-6171
[10]   The hallmarks of cancer [J].
Hanahan, D ;
Weinberg, RA .
CELL, 2000, 100 (01) :57-70